cefepime Powder for solution for injection 500 mg, 1 g, 2 g
Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
PICS
Manufacturer #554
This company focuses on developing and manufacturing a range of pharmaceuticals and healthcare products. Their offerings include prescription medications, over-the-counter drugs, and potentially medical devices or supplements, though specifics are not provided. They appear to have a strong research and development focus, with expertise in several key therapy areas (not specified). The company operates within regions like the EU and North America, adhering to stringent GMP certifications for production. While patent information is unavailable, their commitment to innovation is evident through their product development pipeline.
Manufacturer usually replies in 4 days
Cefepime is an antibiotic used to treat a wide range of bacterial infections, including intraabdominal, kidney, skin, urinary tract infections as well as pneumonia. Suppliers of cefepime market it in the form of powders for injectable solutions.
The developer and earliest manufacturer of cefepime is Bristol-Myers Squibb who first introduced it into the market in 1994 under the trade name Maxipime. Currently, major manufacturers of cefepime medications include companies such as Berr Chem, Hangzhou Viwa, Nectar Lifesciences, ACS Dobfar, and Qilu Pharmaceutical.
Cefepime suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified cefepime manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 10g of cefepime powder falls into an approximate range of 120 EUR to 160 EUR.